Bronchitis
📧 Sign up to get email alerts when something new happens for Bronchitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-07-23FDA Approved: CEFDINIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for cefdinir (CEFDINIR). The approval authorizes changes to the cefdi…
-
FDA approval · 2008-06-16FDA Approved: CEFPODOXIME PROXETIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for cefpodoxime proxetil from Aurobindo Pharma Limited, marking a regulatory action on this generic …
-
CLINICAL_TRIALS trial_result · 2008-06-03Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis [Phase 3]
A Phase 3 trial evaluating faropenem medoxomil for chronic bronchitis was terminated, with no efficacy or safety conclusions provided in the…
-
CLINICAL_TRIALS trial_result · 2008-05-23Clinical Trial Update: Procalcitonin as a Marker of Bacterial Pneumonia [NA]
A completed clinical trial evaluating procalcitonin as a biomarker for bacterial pneumonia in patients with pneumonia, bronchitis, or COPD.
-
CLINICAL_TRIALS trial_result · 2008-03-25Clinical Trial Update: Helium:Oxygen Noninvasive Positive Pressure Ventilation in Patients Exposed to Sulfur Mustard [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating helium-oxygen noninvasive positive pressure ventilation for patients exposed to sulfur mustard has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-13Clinical Trial Update: Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF) [NA]
A completed clinical trial evaluating standard versus biofilm susceptibility testing in cystic fibrosis patients.
-
FDA approval · 2008-03-10FDA Approved: CEFPROZIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Cefprozil from Teva Pharmaceuticals USA, Inc., updating labeling or indications for the anti…
-
CLINICAL_TRIALS trial_result · 2008-02-06Clinical Trial Update: Phase 4 Study - Mucinex D as Adjunct Therapy [Phase 4]
A Phase 4 clinical trial evaluating Mucinex D as adjunct therapy for acute respiratory infection, bronchitis, and rhinosinusitis has complet…
-
FDA approval · 2008-01-16FDA Approved: CEFPROZIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for cefprozil from Lupin Pharmaceuticals, Inc., resulting in updated labeling under the supplemental…
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: Phase 2 Study - Erdosteine in Patients With CB/COPD [Phase 2]
A completed Phase 2 trial evaluating erdosteine in chronic bronchitis and chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2007-10-31Clinical Trial Update: Outcomes of Patients Not Responding to Antibiotics in the Community [NA]
Update on outcomes for patients in the community who did not respond to antibiotics.
-
FDA approval · 2007-09-06FDA Approved: GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE — Supplemental Application (WALGREEN COMPANY)
FDA approved Walgreens' supplemental application for Guaifenesin and Pseudoephedrine Hydrochloride.
-
FDA label_change · 2007-06-05FDA Approved: BACTRIM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for BACTRIM (sulfamethoxazole and trimethoprim) to modify the labeling.
-
CLINICAL_TRIALS trial_result · 2007-05-04Clinical Trial Update: The Effect of Breathing Helium-Hyperoxia During Pulmonary Rehabilitation in Patients With COPD [Phase 2]
This Clinical Trial Update reports the completion of a Phase 2 study assessing inhaled helium-oxygen (helium-hyperoxia) during pulmonary reh…
-
FDA approval · 2007-04-06FDA Approved: CEFDINIR — Original Application (Sandoz Inc)
FDA approved Sandoz's original ANDA for cefdinir, a generic cephalosporin antibiotic.
-
FDA approval · 2007-01-30FDA Approved: CEFPROZIL — Original Application (Aurobindo Pharma Limited)
The FDA approved the original application for cefprozil from Aurobindo Pharma Limited, making a generic cephalosporin antibiotic available i…
-
CLINICAL_TRIALS trial_result · 2006-09-04Clinical Trial Update: Cardiopulmonary Effects of Particulate Exposure
This completed NIEHS-sponsored clinical trial evaluated the cardiopulmonary effects of exposure to particulate matter, examining respiratory…
-
FDA approval · 2006-08-23FDA Approved: MUCINEX — Supplemental Application (RB Health (US) LLC)
FDA approved a supplemental application for Mucinex (guaifenesin) from RB Health (US) LLC, indicating FDA action on a supplemental submissio…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD) [Phase 1, Phase 2]
An NCCIH-sponsored trial evaluated yoga as a non-pharmacologic approach to alleviate shortness of breath in chronic obstructive pulmonary di…
-
FDA approval · 2006-05-19FDA Approved: CEFDINIR — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin's generic cefdinir (CEFDINIR) under an Original Application (ANDA065264), providing a new generic cephalosporin option.